益盛药业：第九届董事会第二次会议决议公告

Core Viewpoint - Yisheng Pharmaceutical announced the approval of its 2025 semi-annual report and summary by the company's ninth board of directors during its second meeting [2] Group 1 - The announcement was made on the evening of August 22 [2] - The report includes financial performance and operational highlights for the first half of 2025 [2]